Mast Therapeutics shareholders to vote on proposed Savara merger on April 21

• Mast Therapeutics (MSTX) sets the date for its special meeting of shareholders to vote on the proposed merger with Savara. The meeting will commence at 9:00 am PT on April 21 in San Diego, CA.
• Previously: Mast Therapeutics and Savara to merge in all-stock deal (Jan. 8)